Collectively, wild-type p53 inhibits the shift from oxidative phosphorylation to glycolysis [116,117], promotes fatty acid oxidation while preventing lipid accumulation in cancer cells [118] and does so by modulating hundreds of targets [119]. The gene discussed is TP53; the disease is cancer.